Alshayeb Hala, Wall Barry M
University of Tennessee Health Science Center, Department of Internal Medicine, 956 Court Avenue, Room H314, Memphis, TN 38163, USA.
Cases J. 2009 Sep 15;2:7201. doi: 10.1186/1757-1626-0002-0000007201.
Although membranoproliferative glomerulonephritis has been reported to occur in association with non-Hodgkin's lymphoma, information concerning the long term effects of treatment of non-Hodgkin's lymphoma on the associated membranoproliferative glomerulonephritis is limited.
The current report describes a patient who presented with the abrupt onset of hypertension, mixed nephritic/nephrotic syndrome and acute renal failure. Kidney biopsy was consistent with membranoproliferative glomerulonephritis, type 1. Bone marrow biopsy performed in the evaluation of periaortic lymphadenopathy, hepatosplenomegaly, and thrombocytopenia confirmed the diagnosis of low grade B-cell non-Hodgkin's lymphoma. The patient's renal function improved and proteinuria resolved after initial treatment of non-Hodgkin's lymphoma with chemotherapy. During eleven years of follow up, membranoproliferative glomerulonephritis has remained in remission, as confirmed by repeatedly negative urinalyses, normal blood pressure and absence of clinical signs and symptoms suggestive of nephritic/nephrotic syndrome.
Membranoproliferative glomerulonephritis has been known to be associated with both chronic lymphocytic leukemia and non-Hodgkin's lymphoma, particularly with B cell lymphocytic type non-Hodgkin's lymphoma. There is limited information available concerning the effects of treatment of non-Hodgkin's lymphoma on the progression of non-Hodgkin's lymphoma associated membranoproliferative glomerulonephritis. In the few reported cases we found, long term follow up after initial resolution of the membranoproliferative glomerulonephritis was lacking. This report presented a rare case of non-Hodgkin's lymphoma associated membranoproliferative glomerulonephritis, that continued to be in remission during eleven years of follow up after initial chemotherapy treatment of lymphoma.
尽管已有膜增生性肾小球肾炎与非霍奇金淋巴瘤相关的报道,但关于非霍奇金淋巴瘤治疗对相关膜增生性肾小球肾炎的长期影响的信息有限。
本报告描述了一名患者,其突然出现高血压、混合性肾炎/肾病综合征及急性肾衰竭。肾脏活检符合1型膜增生性肾小球肾炎。在评估腹主动脉旁淋巴结肿大、肝脾肿大及血小板减少症时进行的骨髓活检确诊为低度B细胞非霍奇金淋巴瘤。该患者在接受非霍奇金淋巴瘤化疗初始治疗后,肾功能改善,蛋白尿消失。在11年的随访中,膜增生性肾小球肾炎一直处于缓解状态,多次尿液分析阴性、血压正常以及无提示肾炎/肾病综合征的临床体征和症状均证实了这一点。
已知膜增生性肾小球肾炎与慢性淋巴细胞白血病和非霍奇金淋巴瘤均相关,尤其是B细胞淋巴细胞型非霍奇金淋巴瘤。关于非霍奇金淋巴瘤治疗对非霍奇金淋巴瘤相关膜增生性肾小球肾炎进展的影响,现有信息有限。在我们发现的少数报道病例中,缺乏膜增生性肾小球肾炎初始缓解后的长期随访。本报告呈现了一例罕见的非霍奇金淋巴瘤相关膜增生性肾小球肾炎病例,该病例在淋巴瘤初始化疗治疗后的11年随访期间持续缓解。